Ozempic
Semaglutide
Semaglutide therapy with physician oversight
GLP-1 prescription medication FDA-approved for type 2 diabetes and prescribed off-label for weight management.
When used for weight management, Ozempic® is prescribed off-label under clinician supervision.

About Ozempic
Ozempic® is an FDA-approved semaglutide injection for type 2 diabetes. In appropriate clinical contexts, it may also be considered off-label for weight management when a licensed provider determines it is medically suitable.
Key benefits
- Supports blood sugar control in type 2 diabetes
- May reduce appetite as part of a supervised weight plan
- Established clinical track record under medical monitoring
- Weekly injection schedule
Who may qualify
- Determined individually based on diagnosis, BMI, and health history
- Off-label weight use requires explicit clinician judgment
- Contraindications and drug interactions carefully reviewed
How treatment works
Medical evaluation
Your clinician reviews diabetes status, weight goals, and overall health.
Treatment decision
If appropriate, a prescription and titration plan are created for your needs.
Ongoing follow-up
Regular visits monitor glucose trends, weight, and side effects.
Good to know
- Off-label weight use is not FDA-approved for that indication.
- Side effects may include nausea, vomiting, or constipation.
- Not a substitute for comprehensive lifestyle and medical care.
GLP-1 medications are available by prescription only after a licensed provider determines eligibility. This information is educational and not medical advice.
Common questions
It may be prescribed off-label for weight management when a licensed clinician determines it is clinically appropriate. This is a medical decision based on your individual profile.
Coverage depends on your plan, diagnosis, and formulary. Our team can help you explore benefits during your evaluation.